C07J 31/00
Normal steroids containing one or more sulfur atoms not belonging to a
Official title: Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
C07J31/00 (Normal steroids containing one or more sulfur atoms not belonging to a) appears on 696 US grants and 537 published applications in this corpus.
Search patents in C07J- Granted patents
- 696
- Published applications
- 537
- Assignees
- 325
- Inventors
- 1,468
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 13 | 0 |
| 1978 | 20 | 0 |
| 1979 | 13 | 0 |
| 1980 | 23 | 0 |
| 1981 | 13 | 0 |
| 1982 | 19 | 0 |
| 1983 | 12 | 0 |
| 1984 | 19 | 0 |
| 1985 | 14 | 0 |
| 1986 | 17 | 0 |
| 1987 | 14 | 0 |
| 1988 | 4 | 0 |
| 1989 | 15 | 0 |
| 1990 | 18 | 0 |
| 1991 | 13 | 0 |
| 1992 | 14 | 0 |
| 1993 | 14 | 0 |
| 1994 | 13 | 0 |
| 1995 | 19 | 0 |
| 1996 | 14 | 0 |
| 1997 | 25 | 0 |
| 1998 | 18 | 0 |
| 1999 | 17 | 0 |
| 2000 | 7 | 0 |
| 2001 | 16 | 0 |
| 2002 | 10 | 22 |
| 2003 | 13 | 17 |
| 2004 | 8 | 14 |
| 2005 | 6 | 19 |
| 2006 | 10 | 10 |
| 2007 | 6 | 17 |
| 2008 | 2 | 9 |
| 2009 | 2 | 9 |
| 2010 | 8 | 13 |
| 2011 | 8 | 13 |
| 2012 | 8 | 14 |
| 2013 | 11 | 15 |
| 2014 | 12 | 17 |
| 2015 | 4 | 22 |
| 2016 | 21 | 40 |
| 2017 | 26 | 30 |
| 2018 | 21 | 35 |
| 2019 | 30 | 33 |
| 2020 | 24 | 31 |
| 2021 | 19 | 40 |
| 2022 | 17 | 27 |
| 2023 | 9 | 31 |
| 2024 | 9 | 18 |
| 2025 | 13 | 28 |
| 2026 | 8 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Process for preparing b-[(7α, 17β)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid and process intermediates15 Sep 2026US 12,735,447 B2Industriale Chimica S.R.L.
- Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for preparing same28 Jul 2026US 12,692,288 B2Medicis Pharmaceutical Corporation
- Synthesis of cholesterol and vitamin D3 from phytosterols9 Jun 2026US 12,649,762 B2Fermenta Biotech Limited
- Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions12 May 2026US 12,622,872 B2Nicox Ophthalmics, Inc.
- Process for preparing B-[(7a, 1713)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid14 Apr 2026US 12,600,745 B2Industriale Chimica S.R.L.
- Steroid-cationic lipid compound and use thereof8 Oct 2026US 2026/0306406 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Lipids and nanoparticle formulations thereof1 Oct 2026US 2026/0295080 A1Arcturus Therapeutics, Inc.
- Lymph directing prodrugs24 Sep 2026US 2026/0284004 A1Monash University
- 25-hydroxy-cholest-5-en-3-sulfate choline, formulations thereof and methods for preparing, and uses of same23 Jul 2026US 2026/0207628 A1Durect Corporation
- Glucocorticoid receptor agonist and conjugate thereof16 Jul 2026US 2026/0199497 A1Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Most cited
By later US patents
- Androstane carbothioates130US 4,335,121 AGlaxo Group Limited · 1982
- Neuroactive steroids of the androstane and pregnane series114US 5,925,630 ACoCensys, Inc. · 1999
- Estrogenic compounds as anti-angiogenic agents112US 5,504,074 AChildren's Medical Center Corporation · 1996
- Soft steroids having anti-inflammatory activity100US 4,996,335 A1991
- Pharmaceutical compositions and methods of transporting compounds across biological membrane93US 5,455,335 AThe Trustees of Princeton University · 1995